N@N

Market Maker Surveillance Report. GILD, FNFG, PCG, MSLP, OMVJF, GEN, Highest Net Sell Volume and Negative Price Friction For T

June 21, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3560 companies with "abnormal" market making, 4305 companies with positive Friction Factors and 1695 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Tuesday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. GILEAD SCIENCES, INC. (NASDAQ:GILD), FIRST NIAGARA FINANCIAL GRP (NASDAQ:FNFG), P G & E CORP (NYSE:PCG), MUSCLE PHARM CORP (OTC:MSLP), OMV AG (OTC:OMVJF), GENON ENERGY INC (NYSE:GEN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     GILD       $-0.200      -0.49%       2,817,968       41.18%       4,021,594       58.78%       -1,203,626      -60,181 
     FNFG       $-0.040      -0.29%       939,071         23.12%       3,122,357       76.87%       -2,183,286      -545,822
     PCG        $-0.150      -0.35%       641,254         13.53%       3,419,627       72.13%       -2,778,373      -185,225
     MSLP       $-0.011      -24.44%      4,108,404       35.31%       6,691,359       57.51%       -2,582,955      -2,348,141
     OMVJF      $-0.840      -1.96%       3,880,000       23.69%       12,500,000      76.31%       -8,620,000      -102,619
     GEN        $-0.010      -0.27%       3,048,808       21.77%       5,182,027       37.00%       -2,133,219      -2,133,219

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have low price friction combined with more selling than buying (negative Net Volume) in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows GILD down $-0.20000 with a Friction Factor of -60,181 and a Net Volume of -1,203,626. That means that it takes 60,181 more shares of selling than buying to drop GILD by one penny. On Monday the Market Makers allowed the stock to move down on heavier selling than buying (low negative friction).

GILEAD SCIENCES, INC. (NASDAQ:GILD) - Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The companys products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular age-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a Quad regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The companys Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Foster City, California.

FIRST NIAGARA FINANCIAL GRP (NASDAQ:FNFG) - First Niagara Financial Group, Inc. operates as the holding company for First Niagara Bank, N.A. that provides retail and commercial banking, and other financial services to individuals, families, and businesses. It offers retail deposit accounts, which include savings, negotiable order of withdrawal, checking, money market, and certificate of deposit accounts, as well as provides business savings and checking, money market, cash management accounts, and municipal deposit accounts. The companys loan portfolio comprises commercial real estate and multi-family loans; commercial business loans; residential real estate loans; home equity loans; and consumer loans consisting of indirect mobile home loans, and personal secured and unsecured loans. It also sells insurance products, including commercial and personal insurance, surety bond, life, disability, and long-term care coverage products. In addition, the company offers risk management consulting services comprising alternative risk and self-insurance services, claims investigation and adjusting services, and third party administration services for self insured workers compensation plans. Further, it provides employee benefits plan and compensation consulting services. Additionally, First Niagara Financial Group offers wealth management services that manage client funds utilizing various third party investment vehicles consisting of stocks, bonds, mutual funds, and annuities, as well as other investment products, such as individual retirement accounts, education savings plans, and retirement plans. As of December 31, 2010 it operated 257 bank branches, including 115 in Upstate New York and 142 branches in Pennsylvania. The company was founded in 1870 and is based in Buffalo, New York.

P G & E CORP (NYSE:PCG) - PG&E Corporation, through its subsidiaries, operates as a public utility company that engages in electricity and natural gas distribution primarily in northern and central California. The company also involves in the generation, procurement, transmission, and distribution of electricity; and procurement, transportation, storage, and distribution of natural gas. It owns and operates electricity generation facilities, transmission and distribution lines, and substations; and an integrated natural gas transportation, storage, and distribution system, as well as has underground natural gas storage fields in California. The company serves residential, commercial, industrial, agricultural, public street and highway lighting, and other electric utility customers. As of December 31, 2009, it served approximately 5.1 million electricity distribution customers and approximately 4.3 million natural gas distribution customers. The company also operated 18,650 circuit miles of interconnected transmission lines and 141,213 circuit miles of distribution lines for electricity; and 42,142 miles of distribution pipelines, 6,438 miles of backbone and local transmission pipelines, and 3 storage facilities for natural gas. PG&E Corporation was founded in 1905 and is based in San Francisco, California.

MUSCLE PHARM CORP (OTC:MSLP) - MusclePharm Corporation manufactures and markets sports nutrition products for athletes, body builders, and health minded individuals in the United States and internationally. The companys nutrition products consist of vitamins, minerals, herbs, and dietary supplements. Its product portfolio includes Assault, a combination of clinically proven, naturally occurring substances for providing muscles with increased energy at the cellular level; Battle Fuel that comprises natural compounds to impact the bodys hormonal, recovery, and immune pathways; Bullet Proof, a clinically proven combination of natural components to support the restful state of sleep possible, as well as to optimize recovery and repair through specific hormonal modulation and precise nutrient delivery. The companys products also comprise Combat Powder, a timed-released protein super-food; Shred Matrix that includes natural compounds to impact the bodys multiple metabolic, energy, and performance pathways; and Recon that consists of BCAAs and EAAs for muscle building. It sells its products under the MusclePharm brand name. The company markets its products directly, as well as through retail stores, distributors, and Internet sites. MusclePharm Corporation was founded in 2008 and is based in Aurora, Colorado.

OMV AG (OTC:OMVJF) - OMV Aktiengesellschaft, an integrated energy supplier, engages in the exploration and development of oil and gas resources, and supplies energy in central and southeastern Europe. It operates in three segments: Exploration and Production (E&P); Refining and Marketing, including petrochemicals (R&M); and Gas and Power (G&P). The companys E&P segment engages in the exploration, development, and production of oil and gas primarily in central and southeastern Europe, North Africa, north-west Europe, the Middle East, Australia and New Zealand, and the Russian Federation and the Caspian Region. As of December 31, 2009, it had proved hydrocarbon reserves of approximately 1,118 million barrels of oil equivalent and proved oil and gas reserves of approximately 1,870 million barrels of oil equivalent. The companys R&M segment operates refineries that process oil and gas into petroleum products in Schwechat, Austria; Burghausen, southern Germany; and Arpechim and Petrobrazi, Romania. This segment also operates a network of approximately 2,433 filling stations in 13 central and southeast European countries. Its G&P segment engages in the gas transit through the transport within Austria, as well as in the gas storage, marketing, and trading. It operates 2,000 kilometer pipeline network and gas storage facilities with a capacity of approximately 2.3 billion cubic meters, as well as gas fired power plants. The company also produces polyolefins and melamine. OMV Aktiengesellschaft was founded in 1956 and is based in Vienna, Austria.

GENON ENERGY INC (NYSE:GEN) - GenOn Energy, Inc. operates as a generator of wholesale electricity in the United States. Its portfolio of power generation facilities include baseload, intermediate, and peaking units using coal, natural gas, and oil to generate electricity. The company owns, contracts, or operates approximately 49 power generation stations with generation capacity of 24,599 megawatts. The company was formerly known as Mirant Corporation and changed its name to GenOn Energy, Inc. on December 4, 2010. The company is based in Houston, Texas.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net